| CDHIX | VFWPX | CDHIX / VFWPX | |
| Total Expense Ratio | 0.29 | 0.03 | 967% |
| Annual Report Gross Expense Ratio | 0.40 | 0.03 | 1,333% |
| Fund Existence | 10 years | 15 years | - |
| Gain YTD | 3.935 | 4.210 | 93% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 100000000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.33B | 78.2B | 2% |
| Annual Yield % from dividends | 3.39 | 3.10 | 109% |
| Returns for 1 year | 37.56 | 34.53 | 109% |
| Returns for 3 years | 62.45 | 46.09 | 136% |
| Returns for 5 years | 56.32 | 32.70 | 172% |
| Returns for 10 years | 167.80 | 110.03 | 153% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VGVT | 76.40 | 0.12 | +0.15% |
| Vanguard Government Securities Actv ETF | |||
| ECML | 34.73 | N/A | N/A |
| Euclidean Fundamental Value ETF | |||
| ULST | 40.56 | -0.01 | -0.01% |
| State Street® Ultra Short Term Bond ETF | |||
| JULH | 24.95 | N/A | -0.02% |
| Innovator Premium Income 20 Bar ETF -Jul | |||
| XBI | 124.35 | -2.47 | -1.95% |
| State Street® SPDR® S&P® Biotech ETF | |||